← The SEC Ephemeris: the whole map
Nevakar, Inc. Norepinephrine Bitartrate
In the graph: all 1 documents (2 pages).
- Application
- NDA 214628
- Ticker
- Nevakar, Inc.
- Product
- Norepinephrine Bitartrate
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- June 14, 2021
From FDA letters and SEC filings. Not investment or medical advice.